Bevacizumab has transformed cancer treatment by targeting the tumour’s blood supply to inhibit its growth. From metastatic colorectal cancer to glioblastoma multiforme and cervical cancer, its versatility

Breast cancer is one of the most prevalent cancers worldwide, impacting millions of women—and, increasingly, men—every year. While its prevalence can be alarming, the positive news is that breast cancer

Cancer is one of the most challenging health conditions to navigate, but thanks to advances in medical treatments, many people are living longer, healthier lives after diagnosis. While medications play

Cervical cancer is the most common among women. It can be caused by various factors like Human papillomavirus (HPV), smoking, weakened immunity, multiple sex and family history. Thus, there is an increased

Bevacizumab is a recombinant monoclonal antibody that blocks the growth of new blood vessels (angiogenesis). It is often used in the treatment of various advanced cancers. It is developed to prevent the

An up-to-date research report has been disclosed by Market Research Hub highlighting the title “Global Bevacizumab Biosimilar Market Research Report 2018” which provides an outlook of current market growth

The recently published report titled Global Bevacizumab Industry 2018 Market Research Report is an in depth study providing complete analysis of the industry for the period 2018 – 2025.